Evidence map›Paper›PMID 39844374›Full record

ArticleEpidemiology and infection2025

SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022.

Sophie L Campman, Anders Boyd, Janke Schinkel, Liza Coyer, Charles Agyemang, Henrike Galenkamp, Anitra D M Koopman, Felix P Chilunga, Jelle Koopsen, Aeilko H Zwinderman and 3 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Sophie L CampmanDepartment of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-3910-378X
Anders BoydDepartment of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
Janke SchinkelAmsterdam UMC location AMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.
Liza CoyerDepartment of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-5830-2982
Charles AgyemangDepartment of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Henrike GalenkampDepartment of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Anitra D M KoopmanDepartment of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Felix P ChilungaDepartment of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Jelle KoopsenDepartment of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
Aeilko H ZwindermanAmsterdam UMC location University of Amsterdam, Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam, The Netherlands.
Suzanne JurriaansAmsterdam UMC location AMC, University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.
Karien StronksDepartment of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Maria PrinsDepartment of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.

Funding

ZonMw 10430022010002
6 · The paper itself

Abstract

We studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccination status among six ethnic groups in Amsterdam, the Netherlands. We analysed participants of the Healthy Life in an Urban Setting cohort who were tested for SARS-CoV-2 spike protein antibodies between 17 May and 21 November 2022. We categorized participants with antibodies as only infected, only vaccinated (≥1 dose), or both infected and vaccinated, based on self-reported prior infection and vaccination status and previous seroprevalence data. We compared infection and vaccination status between ethnic groups using multivariable, multinomial logistic regression. Of the 1,482 included participants, 98.5% had SARS-CoV-2 antibodies (

Indexed as

COVID-19COVID-19 VaccinesEthnicitySARS-CoV-2VaccinationAdolescentAdultAgedAntibodies, ViralFemaleHumansMaleMiddle AgedNetherlandsSeroepidemiologic StudiesYoung AdultAntibodies, ViralCOVID-19 VaccinesantibodiesethnicityimmunitySARS-CoV-2seroprevalencevaccination

Identifiers

PMID39844374
PMCPMC11822580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.